Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-031453
Date:2023-05-18
Issuer: CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP)
Original Submission Date:

Reporting Person:

HOLMER ALAN F
C/O CORBUS PHARMACEUTICALS HOLDINGS, INC
500 RIVER RIDGE DRIVE NORWOOD, MA 02062

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 9.96 2023-05-18 deemed execution date A 5,300 (a) 2033-05-18 common stock 5,300 $9.96 5,300 direct
Footnotes
IDfootnote
f1 the annual option award was made in accordance with the terms of the issuer's 2014 equity compensation plan. the option will vest 100% on the one year anniversay from the date of grant.
WhaleWisdom Logo

Elevate your investments